{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:57:04Z","timestamp":1787590624879,"version":"build-2736575974"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"AIRC-IG","award":["20106"],"award-info":[{"award-number":["20106"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Meningiomas are mainly benign brain tumors, although about 20% of histologically benign cases are clinically aggressive and recur after resection. We hypothesize that meningioma brain invasiveness and recurrence may be related to the presence of cancer stem cells and their high responsiveness to the CXCL12-CXCR4\/CXCR7 chemokine axis. The aim of this study was to isolate meningioma stem cells from human samples, characterize them for biological features related to malignant behavior, and to identify the role of CXCR4\/CXCR7 in these processes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Meningioma stem cells were isolated from patient-derived primary cultures in stem cell-permissive conditions, and characterized for phenotype, self-renewal, proliferation and migration rates, vasculogenic mimicry (VM), and in vivo tumorigenesis, in comparison with differentiated meningioma cells and stem-like cells isolated from normal meninges. These cell populations were challenged with CXCL12 and CXCL11 and receptor antagonists to define the chemokine role in stem cell-related functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Stem-like cells isolated from meningioma cultures display higher proliferation and migration rates, and VM, as compared to meningioma non-stem cells or cells isolated from normal meninges and were the only tumorigenic population in vivo. In meningioma cells, these stem-like functions were under the control of the CXCR4\/CXCR7 chemokine axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We report a role for CXCL11 and CXCL12 in the control of malignant features in stem-like cells isolated from human meningioma, providing a possible basis for the aggressive clinical behavior observed in subsets of these tumors. CXCR4\/CXCR7 antagonists might represent a useful approach for meningioma at high risk of recurrence and malignant progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noad076","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T12:50:00Z","timestamp":1681908600000},"page":"1775-1787","source":"Crossref","is-referenced-by-count":23,"title":["Stem-like signatures in human meningioma cells are under the control of CXCL11\/CXCL12 chemokine activity"],"prefix":"10.1093","volume":"25","author":[{"given":"Federica","family":"Barbieri","sequence":"first","affiliation":[{"name":"Section of Pharmacology, Department of Internal Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Bajetto","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Internal Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Dellacasagrande","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Internal Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Solari","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Internal Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"W\u00fcrth","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Internal Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Neurobiology of miRNA, Istituto Italiano di Tecnologia (IIT) , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rancati","sequence":"additional","affiliation":[{"name":"Neurobiology of miRNA, Istituto Italiano di Tecnologia (IIT) , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ceresa","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Appolloni","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppa","family":"De Luca","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Dono","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Nozza","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Schiapparelli","sequence":"additional","affiliation":[{"name":"Medical Physics Department, E.O. Galliera Hospital , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gambaro","sequence":"additional","affiliation":[{"name":"Medical Physics Department, E.O. Galliera Hospital , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Fiaschi","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"},{"name":"Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Gaggero","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Costanzo","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Internal Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Thellung","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Internal Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Malatesta","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"},{"name":"Department of Experimental Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Pagano","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"},{"name":"Department of Experimental Medicine, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zona","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"},{"name":"Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"De Pietri Tonelli","sequence":"additional","affiliation":[{"name":"Neurobiology of miRNA, Istituto Italiano di Tecnologia (IIT) , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2394-996X","authenticated-orcid":false,"given":"Tullio","family":"Florio","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Internal Medicine, University of Genova , Genova , Italy"},{"name":"IRCCS Ospedale Policlinico San Martino , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"2023100321360867900_CIT0001","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol."},{"issue":"6","key":"2023100321360867900_CIT0002","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"11","key":"2023100321360867900_CIT0003","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"issue":"7874","key":"2023100321360867900_CIT0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature."},{"key":"2023100321360867900_CIT0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clineuro.2016.01.006","article-title":"WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant","volume":"141","author":"Gallagher","year":"2016","journal-title":"Clin Neurol Neurosurg."},{"issue":"6","key":"2023100321360867900_CIT0006","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/CCO.0000000000000687","article-title":"Molecular alterations in meningioma: Prognostic and therapeutic perspectives","volume":"32","author":"Birzu","year":"2020","journal-title":"Curr Opin Oncol."},{"issue":"19\u201320","key":"2023100321360867900_CIT0007","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.drudis.2012.06.001","article-title":"The status of the art of human malignant glioma management: The promising role of targeting tumor-initiating cells","volume":"17","author":"Florio","year":"2012","journal-title":"Drug Discov Today"},{"issue":"19","key":"2023100321360867900_CIT0008","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.7150\/thno.41648","article-title":"Stem cell programs in cancer initiation, progression, and therapy resistance","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"2023100321360867900_CIT0009","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yexmp.2010.12.003","article-title":"Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma","volume":"90","author":"Rath","year":"2011","journal-title":"Exp Mol Pathol."},{"issue":"4","key":"2023100321360867900_CIT0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jmcb\/mjx023","article-title":"KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas","volume":"9","author":"Tang","year":"2017","journal-title":"J Mol Cell Biol."},{"issue":"8","key":"2023100321360867900_CIT0011","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/mc.22653","article-title":"NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades","volume":"56","author":"Freitag","year":"2017","journal-title":"Mol Carcinog."},{"issue":"4","key":"2023100321360867900_CIT0012","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3892\/ijo.2013.2053","article-title":"Isolation of mesenchymal stem-like cells in meningioma specimens","volume":"43","author":"Lim","year":"2013","journal-title":"Int J Oncol."},{"issue":"3","key":"2023100321360867900_CIT0013","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-011-0705-3","article-title":"Identification of CD105 (endoglin)-positive stem-like cells in rhabdoid meningioma","volume":"106","author":"Hu","year":"2012","journal-title":"J Neurooncol."},{"key":"2023100321360867900_CIT0014","doi-asserted-by":"crossref","first-page":"892004","DOI":"10.3389\/fonc.2022.892004","article-title":"Synthesizing molecular and immune characteristics to move beyond WHO grade in meningiomas: A focused review","volume":"12","author":"Kannapadi","year":"2022","journal-title":"Front Oncol."},{"issue":"3","key":"2023100321360867900_CIT0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/cancers13030469","article-title":"The CXCL12 crossroads in cancer stem cells and their niche","volume":"13","author":"Lopez-Gil","year":"2021","journal-title":"Cancers"},{"key":"2023100321360867900_CIT0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-030-62658-7_4","article-title":"CXCL11 signaling in the tumor microenvironment","volume":"1302","author":"Gao","year":"2021","journal-title":"Adv Exp Med Biol."},{"key":"2023100321360867900_CIT0017","doi-asserted-by":"crossref","first-page":"574667","DOI":"10.3389\/fphar.2020.574667","article-title":"The role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front Pharmacol."},{"issue":"3","key":"2023100321360867900_CIT0018","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1096\/fj.08-116749","article-title":"Imaging chemokine receptor dimerization with firefly luciferase complementation","volume":"23","author":"Luker","year":"2009","journal-title":"FASEB J."},{"issue":"1","key":"2023100321360867900_CIT0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1215\/15228517-2006-023","article-title":"CXCR4 and SDF1 expression in human meningiomas: A proliferative role in tumoral meningothelial cells in vitro","volume":"9","author":"Bajetto","year":"2007","journal-title":"Neuro Oncol"},{"issue":"1","key":"2023100321360867900_CIT0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1196\/annals.1378.037","article-title":"CXC receptor and chemokine expression in human meningioma: SDF1\/CXCR4 signaling activates ERK1\/2 and stimulates meningioma cell proliferation","volume":"1090","author":"Barbieri","year":"2006","journal-title":"Ann N Y Acad Sci."},{"issue":"1\u20132","key":"2023100321360867900_CIT0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2011.01.006","article-title":"Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature","volume":"234","author":"Wurth","year":"2011","journal-title":"J Neuroimmunol."},{"issue":"1","key":"2023100321360867900_CIT0022","doi-asserted-by":"crossref","first-page":"100813","DOI":"10.1016\/j.isci.2019.100813","article-title":"A xenotransplant model of human brain tumors in wild-type mice","volume":"23","author":"Hoffmann","year":"2020","journal-title":"iScience"},{"issue":"1\u20132","key":"2023100321360867900_CIT0023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:NEON.0000013498.19981.55","article-title":"Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity","volume":"66","author":"Arena","year":"2004","journal-title":"J Neurooncol."},{"issue":"1","key":"2023100321360867900_CIT0024","first-page":"143","article-title":"Differential role of EGF and BFGF in human GBM-TIC proliferation: Relationship to EGFR-tyrosine kinase inhibitor sensibility","volume":"27","author":"Bajetto","year":"2013","journal-title":"J Biol Regul Homeost Agents."},{"issue":"4","key":"2023100321360867900_CIT0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy."},{"issue":"5","key":"2023100321360867900_CIT0026","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/cells10051070","article-title":"Cancer stem cells and neovascularization","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"issue":"7","key":"2023100321360867900_CIT0027","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1134","article-title":"The bicyclam AMD3100 story","volume":"2","author":"De Clercq","year":"2003","journal-title":"Nat Rev Drug Discov."},{"issue":"5","key":"2023100321360867900_CIT0028","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.4049\/jimmunol.0900269","article-title":"Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands","volume":"183","author":"Zabel","year":"2009","journal-title":"J Immunol."},{"issue":"1","key":"2023100321360867900_CIT0029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-021-02213-0","article-title":"Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives","volume":"41","author":"Barbieri","year":"2022","journal-title":"J Exp Clin Cancer Res."},{"issue":"8","key":"2023100321360867900_CIT0030","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"issue":"5","key":"2023100321360867900_CIT0031","doi-asserted-by":"crossref","first-page":"eabm6247","DOI":"10.1126\/sciadv.abm6247","article-title":"Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies","volume":"8","author":"Bayley","year":"2022","journal-title":"Sci Adv."},{"issue":"7","key":"2023100321360867900_CIT0032","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1007\/s12035-016-0025-x","article-title":"Phenotypical and pharmacological characterization of stem-like cells in human pituitary adenomas","volume":"54","author":"Wurth","year":"2017","journal-title":"Mol Neurobiol."},{"key":"2023100321360867900_CIT0033","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jocn.2020.09.037","article-title":"Embryonic stem cell-like subpopulations are present within Schwannoma","volume":"81","author":"Kilmister","year":"2020","journal-title":"J Clin Neurosci."},{"key":"2023100321360867900_CIT0034","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fsurg.2018.00065","article-title":"Expression of embryonic stem cell markers on the microvessels of WHO grade i meningioma","volume":"5","author":"Shivapathasundram","year":"2018","journal-title":"Front Surg"},{"issue":"9","key":"2023100321360867900_CIT0035","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/neuonc\/now031","article-title":"A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus","volume":"18","author":"Nigim","year":"2016","journal-title":"Neuro Oncol"},{"issue":"1","key":"2023100321360867900_CIT0036","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11060-010-0469-1","article-title":"Isolation and characterization of tumor stem-like cells from human meningiomas","volume":"104","author":"Hueng","year":"2011","journal-title":"J Neurooncol."},{"issue":"3","key":"2023100321360867900_CIT0037","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5414\/NP301327","article-title":"Expression of the stem cell marker CD133 in malignant meningioma","volume":"40","author":"Maier","year":"2021","journal-title":"Clin Neuropathol."},{"key":"2023100321360867900_CIT0038","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.wneu.2018.12.067","article-title":"Association between CD133, CD44, and nestin expression and prognostic factors in high-grade meningioma","volume":"124","author":"Kamamoto","year":"2018","journal-title":"World Neurosurg"},{"key":"2023100321360867900_CIT0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12935-018-0571-6","article-title":"In situ characterization of stem cells-like biomarkers in meningiomas","volume":"18","author":"Alamir","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"10","key":"2023100321360867900_CIT0040","first-page":"11223","article-title":"SSTR2 is a prognostic factor and a promising therapeutic target in glioma","volume":"13","author":"He","year":"2021","journal-title":"Am J Transl Res"},{"issue":"1","key":"2023100321360867900_CIT0041","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00701-020-04650-w","article-title":"Meningiomas from a developmental perspective: Exploring the crossroads between meningeal embryology and tumorigenesis","volume":"163","author":"Boetto","year":"2021","journal-title":"Acta Neurochir (Wien)."},{"key":"2023100321360867900_CIT0042","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2017.07.009","article-title":"Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas","volume":"380","author":"Wallesch","year":"2017","journal-title":"J Neurol Sci."},{"issue":"1","key":"2023100321360867900_CIT0043","first-page":"8","article-title":"Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin","volume":"24","author":"Utsuki","year":"2005","journal-title":"Clin Neuropathol."},{"issue":"2","key":"2023100321360867900_CIT0044","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-018-2807-7","article-title":"The expression of the MSC-marker CD73 and of NF2\/Merlin are correlated in meningiomas","volume":"138","author":"Kirches","year":"2018","journal-title":"J Neurooncol."},{"issue":"39","key":"2023100321360867900_CIT0045","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1038\/onc.2012.468","article-title":"miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells","volume":"32","author":"Kliese","year":"2013","journal-title":"Oncogene."},{"issue":"16","key":"2023100321360867900_CIT0046","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1158\/1078-0432.CCR-07-4717","article-title":"Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine\/paracrine cell proliferation in human pituitary adenomas","volume":"14","author":"Barbieri","year":"2008","journal-title":"Clin Cancer Res."},{"key":"2023100321360867900_CIT0047","first-page":"144","article-title":"CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment","volume":"8","author":"Wurth","year":"2014","journal-title":"Front Cell Neurosci."},{"issue":"2\u20133","key":"2023100321360867900_CIT0048","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tox.2013.10.003","article-title":"Inhibition of CXCL12\/CXCR4 autocrine\/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity","volume":"314","author":"Gatti","year":"2013","journal-title":"Toxicology."},{"issue":"1","key":"2023100321360867900_CIT0049","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11060-014-1364-y","article-title":"CXCL12 secreted from glioma stem cells regulates their proliferation","volume":"117","author":"Uemae","year":"2014","journal-title":"J Neurooncol."},{"key":"2023100321360867900_CIT0050","doi-asserted-by":"crossref","first-page":"105092","DOI":"10.1016\/j.phrs.2020.105092","article-title":"Relevance of the CXCR4\/CXCR7-CXCL12 axis and its effect in pathophysiological conditions","volume":"161","author":"Huynh","year":"2020","journal-title":"Pharmacol Res."},{"issue":"11","key":"2023100321360867900_CIT0051","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/ijms19113592","article-title":"Breast cancer: An examination of the potential of ACKR3 to modify the response of CXCR4 to CXCL12","volume":"19","author":"Del Molino Del Barrio","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2023100321360867900_CIT0052","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41388-018-0519-2","article-title":"CXCR7\/CXCR4 heterodimer-induced histone demethylation: A new mechanism of colorectal tumorigenesis","volume":"38","author":"Song","year":"2019","journal-title":"Oncogene."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad076\/50381924\/noad076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/10\/1775\/51840911\/noad076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/10\/1775\/51840911\/noad076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:37:28Z","timestamp":1696354648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/25\/10\/1775\/7131060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":52,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,4,19]]},"published-print":{"date-parts":[[2023,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad076","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,4,19]]}}}